10x Genomics (TXG) SEC Filings: History & Chart

10x Genomics, Inc.(TXG)

Biotechnology · Pleasanton, CA

$80.66-17.08 (-17.47%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About 10x Genomics, Inc.

Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, covering North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company's offerings feature Chromium and Chromium Connect instruments, supported by indispensable items such as microfluidic chips, slides, and reagents. A significant portion of their portfolio focuses on single-cell solutions, leveraging their Chromium platforms. These allow for precise measurement of gene activity at the individual cell level (single cell gene expression), detailed assessment of immune cell function and their targets (single cell immune profiling), exploration of DNA's physical organization and epigenetic modifications (single cell Assay for Transposase Accessible Chromatin - ATAC), and the concurrent quantification of both genetic activity and epigenetic programming across tens of thousands of cells in a single experiment (single cell multiome ATAC + gene expression). Additionally, 10x Genomics offers the Visium spatial gene expression solution, which maps gene activity patterns within specific tissue sections and can also facilitate co-detection of gene expression and proteins when paired with immunofluorescence. Their varied customer base includes academic, governmental, biopharmaceutical, and biotechnology organizations, among others.

Pleasanton, CA

1,178 employees

www.10xgenomics.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Serge Saxonov

View full financials

Form	Filing Date	Accepted	Document
4	Sep 24, 2026	Sep 24, 2026	View filing
4	Sep 24, 2026	Sep 24, 2026	View filing
4	Sep 11, 2026	Sep 11, 2026	View filing
4	Sep 8, 2026	Sep 8, 2026	View filing
SC 13G	Sep 8, 2026	Sep 8, 2026	View filing
4	Sep 3, 2026	Sep 3, 2026	View filing
4	Aug 28, 2026	Aug 28, 2026	View filing
4	Aug 26, 2026	Aug 26, 2026	View filing
4	Aug 26, 2026	Aug 26, 2026	View filing
4	Aug 26, 2026	Aug 26, 2026	View filing
4	Aug 26, 2026	Aug 26, 2026	View filing
4	Aug 24, 2026	Aug 24, 2026	View filing
4	Aug 17, 2026	Aug 17, 2026	View filing
SC 13G/A	Aug 14, 2026	Aug 14, 2026	View filing
4	Aug 13, 2026	Aug 13, 2026	View filing
10-Q	Aug 7, 2026	Aug 6, 2026	View filing
8-K	Aug 6, 2026	Aug 6, 2026	View filing
4	Jun 24, 2026	Jun 24, 2026	View filing
4	Jun 18, 2026	Jun 18, 2026	View filing
4	Jun 8, 2026	Jun 8, 2026	View filing
4	Jun 8, 2026	Jun 8, 2026	View filing
4	Jun 8, 2026	Jun 8, 2026	View filing
4	Jun 8, 2026	Jun 8, 2026	View filing
4	Jun 8, 2026	Jun 8, 2026	View filing
4	Jun 8, 2026	Jun 8, 2026	View filing
8-K	Jun 8, 2026	Jun 8, 2026	View filing
4	May 27, 2026	May 27, 2026	View filing
4	May 27, 2026	May 27, 2026	View filing
4	May 27, 2026	May 27, 2026	View filing
10-Q	May 8, 2026	May 7, 2026	View filing

SEC Filings

Recent Filings